Combined clinical, metabolomic, and polygenic scores for cardiovascular risk prediction

Combining NMR metabolomic, polygenic, and clinical biomarkers with SCORE2 enhanced prediction of first-onset CVD and could have substantial population health benefit if applied at scale.